ADAR1 Capital Management, LLC historic quarter change: USA Other Stocks, New
In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 10 quarters from 2023-12-31 to 2026-06-30, ADAR1 Capital Management, LLC opened 91 positions, added to 56, reduced 37 and sold out of 117.
- Q1 2026: Stock DAMORA THERAPEUTICS INC; Country of operation —; Class COM NEW; Shares before 0.
- Q1 2026: Stock WAVE LIFE SCIENCES LTD; Country of operation —; Class SHS; Shares before 0.
- Q1 2026: Stock LONGEVERON INC; Country of operation United States; Class CL A NEW; Shares before 0.
- Q1 2026: Stock IMMUNIC INC; Country of operation United States; Class COM; Shares before 0.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1940272), 10 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-18); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-18); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-13); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-13); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2023-12-31.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q1 2026 | DAMORA THERAPEUTICS INC
CUSIP 36322Q206 | | COM NEW | 0 | 279,000 | +279,000 | $0 | $7,226,100 | +$7,226,100 | 2026-05-18 |
|---|
| Q1 2026 | WAVE LIFE SCIENCES LTD
CUSIP Y95308105 | | SHS | 0 | 44,900 | +44,900 | $0 | $325,525 | +$325,525 | 2026-05-18 |
|---|
| Q1 2026 | LONGEVERON INC
CUSIP 54303L203 | United States | CL A NEW | 0 | 200,000 | +200,000 | $0 | $208,000 | +$208,000 | 2026-05-18 |
|---|
| Q1 2026 | IMMUNIC INC
CUSIP 4525EP101 | United States | COM | 0 | 30,000 | +30,000 | $0 | $0 | $0 | 2026-05-18 |
|---|
| Q4 2025 | VYNE THERAPEUTICS INC
CUSIP 92941V308 | United States | COM | 0 | 253,791 | +253,791 | $0 | $147,224 | +$147,224 | 2026-02-18 |
|---|
| Q4 2025 | BIOATLA INC
CUSIP 09077B104 | United States | COM | 0 | 183,107 | +183,107 | $0 | $103,950 | +$103,950 | 2026-02-18 |
|---|
| Q4 2025 | INVO FERTILITY INC.
CUSIP 44984F807 | United States | COM | 0 | 26,722 | +26,722 | $0 | $20,111 | +$20,111 | 2026-02-18 |
|---|
| Q3 2025 | ATAI LIFE SCIENCES NV
CUSIP N0731H103 | | SHS | 0 | 913,242 | +913,242 | $0 | $4,831,050 | +$4,831,050 | 2025-11-14 |
|---|
| Q3 2025 | INTELLIGENT BIO SOLUTIONS IN
CUSIP 36151G600 | United States | COM | 0 | 426,433 | +426,433 | $0 | $434,962 | +$434,962 | 2025-11-14 |
|---|
| Q2 2025 | VERVE THERAPEUTICS INC
CUSIP 92539P101 | United States | COM | 0 | 469,018 | +469,018 | $0 | $5,267,072 | +$5,267,072 | 2025-08-14 |
|---|
| Q2 2025 | BLUEPRINT MEDICINES CORP
CUSIP 09627Y109 | United States | COM | 0 | 15,000 | +15,000 | $0 | $1,922,700 | +$1,922,700 | 2025-08-14 |
|---|
| Q2 2025 | BIOATLA INC
CUSIP 09077B104 | United States | COM | 0 | 170,506 | +170,506 | $0 | $67,520 | +$67,520 | 2025-08-14 |
|---|
| Q1 2025 | SPRINGWORKS THERAPEUTICS INC
CUSIP 85205L107 | | COM | 0 | 207,778 | +207,778 | $0 | $9,169,243 | +$9,169,243 | 2025-05-15 |
|---|
| Q1 2025 | INTRA-CELLULAR THERAPIES INC
CUSIP 46116X101 | United States | COM | 0 | 48,044 | +48,044 | $0 | $6,337,964 | +$6,337,964 | 2025-05-15 |
|---|
| Q1 2025 | CARGO THERAPEUTICS INC
CUSIP 14179K101 | United States | COM | 0 | 341,515 | +341,515 | $0 | $1,389,966 | +$1,389,966 | 2025-05-15 |
|---|
| Q1 2025 | CHECKPOINT THERAPEUTICS INC
CUSIP 162828206 | United States | COM NEW | 0 | 305,800 | +305,800 | $0 | $1,235,432 | +$1,235,432 | 2025-05-15 |
|---|
| Q1 2025 | THIRD HARMONIC BIO INC
CUSIP 88427A107 | United States | COM | 0 | 100,000 | +100,000 | $0 | $347,000 | +$347,000 | 2025-05-15 |
|---|
| Q1 2025 | NORDSTROM INC
CUSIP 655664100 | United States | COM | 0 | 12,000 | +12,000 | $0 | $293,400 | +$293,400 | 2025-05-15 |
|---|
| Q1 2025 | COLOMBIER ACQUISITION CORP I
CUSIP G2283U100 | | COM SHS CL A | 0 | 18,513 | +18,513 | $0 | $197,163 | +$197,163 | 2025-05-15 |
|---|
| Q1 2025 | BIOMX INC
CUSIP 09090D301 | | COM NEW | 0 | 299,598 | +299,598 | $0 | $166,487 | +$166,487 | 2025-05-15 |
|---|
| Q1 2025 | VYNE THERAPEUTICS INC
CUSIP 92941V308 | United States | COM | 0 | 70,419 | +70,419 | $0 | $111,262 | +$111,262 | 2025-05-15 |
|---|
| Q1 2025 | XILIO THERAPEUTICS INC
CUSIP 98422T100 | United States | COM | 0 | 40,000 | +40,000 | $0 | $28,976 | +$28,976 | 2025-05-15 |
|---|
| Q4 2024 | AVID BIOSERVICES INC
CUSIP 05368M106 | United States | COM | 0 | 120,000 | +120,000 | $0 | $1,482,000 | +$1,482,000 | 2025-02-13 |
|---|
| Q4 2024 | POSEIDA THERAPEUTICS INC
CUSIP 73730P108 | United States | COM | 0 | 134,109 | +134,109 | $0 | $1,287,446 | +$1,287,446 | 2025-02-13 |
|---|
| Q4 2024 | WAVE LIFE SCIENCES LTD
CUSIP Y95308105 | | SHS | 0 | 21,700 | +21,700 | $0 | $268,429 | +$268,429 | 2025-02-13 |
|---|
| Q4 2024 | INOZYME PHARMA INC
CUSIP 45790W108 | United States | COM | 0 | 76,299 | +76,299 | $0 | $211,348 | +$211,348 | 2025-02-13 |
|---|
| Q4 2024 | ATAI LIFE SCIENCES NV
CUSIP N0731H103 | | SHS | 0 | 100,000 | +100,000 | $0 | $133,000 | +$133,000 | 2025-02-13 |
|---|
| Q4 2024 | LYRA THERAPEUTICS INC
CUSIP 55234L105 | United States | COM | 0 | 533,200 | +533,200 | $0 | $110,052 | +$110,052 | 2025-02-13 |
|---|
| Q4 2024 | MOVANO INC
CUSIP 62459M206 | United States | COM NEW | 0 | 19,146 | +19,146 | $0 | $103,388 | +$103,388 | 2025-02-13 |
|---|
| Q4 2024 | ALLAKOS INC
CUSIP 01671P100 | United States | COM | 0 | 62,264 | +62,264 | $0 | $75,339 | +$75,339 | 2025-02-13 |
|---|
| Q4 2024 | KARYOPHARM THERAPEUTICS INC
CUSIP 48576U106 | United States | COM | 0 | 20,000 | +20,000 | $0 | $13,526 | +$13,526 | 2025-02-13 |
|---|
| Q4 2024 | CONDUIT PHARMACEUTICALS INC
CUSIP 20678X106 | United States | COM | 0 | 11,200 | +11,200 | $0 | $768 | +$768 | 2025-02-13 |
|---|
| Q3 2024 | PIERIS PHARMACEUTICALS INC
CUSIP 720795202 | United States | COM NEW | 0 | 144,641 | +144,641 | $0 | $2,398,148 | +$2,398,148 | 2024-11-14 |
|---|
| Q3 2024 | INTRA-CELLULAR THERAPIES INC
CUSIP 46116X101 | United States | COM | 0 | 13,400 | +13,400 | $0 | $980,478 | +$980,478 | 2024-11-14 |
|---|
| Q3 2024 | REVANCE THERAPEUTICS INC
CUSIP 761330109 | United States | COM | 0 | 182,166 | +182,166 | $0 | $945,442 | +$945,442 | 2024-11-14 |
|---|
| Q3 2024 | POWERSCHOOL HOLDINGS INC
CUSIP 73939C106 | United States | COM CL A | 0 | 30,000 | +30,000 | $0 | $684,300 | +$684,300 | 2024-11-14 |
|---|
| Q3 2024 | BLUEPRINT MEDICINES CORP
CUSIP 09627Y109 | United States | COM | 0 | 5,100 | +5,100 | $0 | $471,750 | +$471,750 | 2024-11-14 |
|---|
| Q3 2024 | BIOMX INC
CUSIP 09090D301 | | COM NEW | 0 | 432,700 | +432,700 | $0 | $441,354 | +$441,354 | 2024-11-14 |
|---|
| Q3 2024 | MOVANO INC
CUSIP 62459M206 | United States | COM | 0 | 1,159,826 | +1,159,826 | $0 | $416,494 | +$416,494 | 2024-11-14 |
|---|
| Q3 2024 | SAGE THERAPEUTICS INC
CUSIP 78667J108 | United States | COM | 0 | 51,650 | +51,650 | $0 | $372,913 | +$372,913 | 2024-11-14 |
|---|
| Q3 2024 | JVSPAC ACQUISITION CORP
CUSIP G5212E105 | | SHS CL A | 0 | 30,000 | +30,000 | $0 | $310,200 | +$310,200 | 2024-11-14 |
|---|
| Q3 2024 | PROPERTYGURU GROUP LTD
CUSIP G7258M108 | | ORD SHS | 0 | 20,000 | +20,000 | $0 | $132,200 | +$132,200 | 2024-11-14 |
|---|
| Q3 2024 | PERIMETER SOLUTIONS SA
CUSIP L7579L106 | | COMMON STOCK | 0 | 9,000 | +9,000 | $0 | $121,050 | +$121,050 | 2024-11-14 |
|---|
| Q3 2024 | NEKTAR THERAPEUTICS
CUSIP 640268108 | United States | COM | 0 | 67,754 | +67,754 | $0 | $88,080 | +$88,080 | 2024-11-14 |
|---|
| Q3 2024 | AI TRANSN ACQUISITION CORP
CUSIP G01490112 | | ORD SHS | 0 | 7,500 | +7,500 | $0 | $78,600 | +$78,600 | 2024-11-14 |
|---|
| Q3 2024 | VIGIL NEUROSCIENCE INC
CUSIP 92673K108 | United States | COM | 0 | 21,737 | +21,737 | $0 | $73,906 | +$73,906 | 2024-11-14 |
|---|
| Q3 2024 | ITERIS INC NEW
CUSIP 46564T107 | United States | COM | 0 | 10,000 | +10,000 | $0 | $71,400 | +$71,400 | 2024-11-14 |
|---|
| Q3 2024 | FIBROGEN INC
CUSIP 31572Q808 | United States | COM | 0 | 120,663 | +120,663 | $0 | $48,193 | +$48,193 | 2024-11-14 |
|---|
| Q3 2024 | NORDSTROM INC
CUSIP 655664100 | United States | COM | 0 | 2,000 | +2,000 | $0 | $44,980 | +$44,980 | 2024-11-14 |
|---|
| Q3 2024 | VERU INC
CUSIP 92536C103 | United States | COM | 0 | 51,000 | +51,000 | $0 | $39,219 | +$39,219 | 2024-11-14 |
|---|
| Q3 2024 | LUMOS PHARMA INC
CUSIP 55028X109 | United States | COM | 0 | 10,000 | +10,000 | $0 | $38,700 | +$38,700 | 2024-11-14 |
|---|
| Q3 2024 | SPRINGWORKS THERAPEUTICS INC
CUSIP 85205L107 | | COM | 0 | 100 | +100 | $0 | $3,204 | +$3,204 | 2024-11-14 |
|---|
| Q2 2024 | KALA BIO INC
CUSIP 483119202 | United States | COM NEW | 0 | 306,067 | +306,067 | $0 | $2,170,015 | +$2,170,015 | 2024-08-13 |
|---|
| Q2 2024 | AVANGRID INC
CUSIP 05351W103 | United States | COM | 0 | 23,000 | +23,000 | $0 | $817,190 | +$817,190 | 2024-08-13 |
|---|
| Q2 2024 | MOVANO INC
CUSIP 62459M107 | United States | COM | 0 | 1,407,000 | +1,407,000 | $0 | $386,925 | +$386,925 | 2024-08-13 |
|---|
| Q2 2024 | ARCA BIOPHARMA INC
CUSIP 00211Y506 | United States | COM | 0 | 84,676 | +84,676 | $0 | $324,309 | +$324,309 | 2024-08-13 |
|---|
| Q2 2024 | VERVE THERAPEUTICS INC
CUSIP 92539P101 | United States | COM | 0 | 44,000 | +44,000 | $0 | $214,720 | +$214,720 | 2024-08-13 |
|---|
| Q2 2024 | CHIMERIX INC
CUSIP 16934W106 | United States | COM | 0 | 178,229 | +178,229 | $0 | $156,129 | +$156,129 | 2024-08-13 |
|---|
| Q2 2024 | CARA THERAPEUTICS INC
CUSIP 140755109 | United States | COM | 0 | 159,469 | +159,469 | $0 | $41,143 | +$41,143 | 2024-08-13 |
|---|
| Q2 2024 | GLYCOMIMETICS INC
CUSIP 38000Q102 | United States | COM | 0 | 135,000 | +135,000 | $0 | $38,016 | +$38,016 | 2024-08-13 |
|---|
| Q2 2024 | RAPT THERAPEUTICS INC
CUSIP 75382E109 | United States | COM | 0 | 7,500 | +7,500 | $0 | $22,875 | +$22,875 | 2024-08-13 |
|---|
| Q2 2024 | OPTINOSE INC
CUSIP 68404V100 | United States | COM | 0 | 3,000 | +3,000 | $0 | $3,120 | +$3,120 | 2024-08-13 |
|---|
| Q2 2024 | XILIO THERAPEUTICS INC
CUSIP 98422T100 | United States | COM | 0 | 1,500 | +1,500 | $0 | $1,421 | +$1,421 | 2024-08-13 |
|---|
| Q1 2024 | BEYOND AIR INC
CUSIP 08862L103 | | COM | 0 | 1,204,820 | +1,204,820 | $0 | $2,096,387 | +$2,096,387 | 2024-05-15 |
|---|
| Q1 2024 | NGM BIOPHARMACEUTICALS INC
CUSIP 62921N105 | United States | COM | 0 | 816,581 | +816,581 | $0 | $1,298,364 | +$1,298,364 | 2024-05-15 |
|---|
| Q1 2024 | ENVVENO MEDICAL CORPORATION
CUSIP 29415J106 | United States | COM | 0 | 201,728 | +201,728 | $0 | $1,097,400 | +$1,097,400 | 2024-05-15 |
|---|
| Q1 2024 | KIORA PHARMACEUTICALS INC
CUSIP 49721T309 | United States | COM NEW | 0 | 1,100,000 | +1,100,000 | $0 | $776,600 | +$776,600 | 2024-05-15 |
|---|
| Q1 2024 | MORPHIC HLDG INC
CUSIP 61775R105 | United States | COM | 0 | 19,701 | +19,701 | $0 | $693,475 | +$693,475 | 2024-05-15 |
|---|
| Q1 2024 | AEROVATE THERAPEUTICS INC
CUSIP 008064107 | United States | COM | 0 | 15,900 | +15,900 | $0 | $470,163 | +$470,163 | 2024-05-15 |
|---|
| Q1 2024 | ARYA SCIENCES ACQU CORP IV
CUSIP G31659108 | United States | CL A | 0 | 40,930 | +40,930 | $0 | $459,644 | +$459,644 | 2024-05-15 |
|---|
| Q1 2024 | INTELLIGENT BIO SOLUTIONS IN
CUSIP 36151G600 | United States | COM | 0 | 108,250 | +108,250 | $0 | $456,815 | +$456,815 | 2024-05-15 |
|---|
| Q1 2024 | VYNE THERAPEUTICS INC
CUSIP 92941V308 | United States | COM | 0 | 110,091 | +110,091 | $0 | $337,979 | +$337,979 | 2024-05-15 |
|---|
| Q1 2024 | SPRUCE BIOSCIENCES INC
CUSIP 85209E109 | United States | COM | 0 | 365,216 | +365,216 | $0 | $287,023 | +$287,023 | 2024-05-15 |
|---|
| Q1 2024 | KEZAR LIFE SCIENCES INC
CUSIP 49372L100 | United States | COM | 0 | 236,623 | +236,623 | $0 | $213,339 | +$213,339 | 2024-05-15 |
|---|
| Q1 2024 | WAVE LIFE SCIENCES LTD
CUSIP Y95308105 | | SHS | 0 | 30,000 | +30,000 | $0 | $185,100 | +$185,100 | 2024-05-15 |
|---|
| Q1 2024 | NUVEI CORPORATION
CUSIP 67079A102 | | SUB VTG SHS | 0 | 5,000 | +5,000 | $0 | $158,100 | +$158,100 | 2024-05-15 |
|---|
| Q1 2024 | FORTE BIOSCIENCES INC
CUSIP 34962G109 | United States | COM | 0 | 170,510 | +170,510 | $0 | $118,709 | +$118,709 | 2024-05-15 |
|---|
| Q1 2024 | ADICET BIO INC
CUSIP 007002108 | United States | COM | 0 | 31,229 | +31,229 | $0 | $73,388 | +$73,388 | 2024-05-15 |
|---|
| Q1 2024 | FIBROGEN INC
CUSIP 31572Q808 | United States | COM | 0 | 21,350 | +21,350 | $0 | $50,172 | +$50,172 | 2024-05-15 |
|---|
| Q1 2024 | IKENA ONCOLOGY INC
CUSIP 45175G108 | United States | COM | 0 | 35,000 | +35,000 | $0 | $49,700 | +$49,700 | 2024-05-15 |
|---|
| Q1 2024 | ELEVATION ONCOLOGY INC
CUSIP 28623U101 | United States | COM | 0 | 8,629 | +8,629 | $0 | $44,267 | +$44,267 | 2024-05-15 |
|---|
| Q1 2024 | IGM BIOSCIENCES INC
CUSIP 449585108 | United States | COM | 0 | 4,000 | +4,000 | $0 | $38,600 | +$38,600 | 2024-05-15 |
|---|
| Q1 2024 | HOOKIPA PHARMA INC
CUSIP 43906K100 | United States | COM | 0 | 50,000 | +50,000 | $0 | $35,600 | +$35,600 | 2024-05-15 |
|---|
| Q1 2024 | RALLYBIO CORP
CUSIP 75120L100 | United States | COM | 0 | 17,942 | +17,942 | $0 | $33,193 | +$33,193 | 2024-05-15 |
|---|
| Q1 2024 | QUINCE THERAPEUTICS INC
CUSIP 22053A107 | United States | COM | 0 | 26,829 | +26,829 | $0 | $28,439 | +$28,439 | 2024-05-15 |
|---|
| Q1 2024 | ONCTERNAL THERAPEUTICS INC
CUSIP 68236P206 | United States | COM NEW | 0 | 2,472 | +2,472 | $0 | $22,248 | +$22,248 | 2024-05-15 |
|---|
| Q1 2024 | BOLT BIOTHERAPEUTICS INC
CUSIP 097702104 | United States | COM | 0 | 5,000 | +5,000 | $0 | $7,000 | +$7,000 | 2024-05-15 |
|---|
| Q1 2024 | BLUEBIRD BIO INC
CUSIP 09609G100 | United States | COM | 0 | 5,000 | +5,000 | $0 | $6,400 | +$6,400 | 2024-05-15 |
|---|
| Q1 2024 | BEYOND MEAT INC
CUSIP 08862E109 | United States | COM | 0 | 577 | +577 | $0 | $4,778 | +$4,778 | 2024-05-15 |
|---|
| Q1 2024 | TALIS BIOMEDICAL CORP
CUSIP 87424L207 | United States | COM NEW | 0 | 300 | +300 | $0 | $2,625 | +$2,625 | 2024-05-15 |
|---|
| Q1 2024 | KARYOPHARM THERAPEUTICS INC
CUSIP 48576U106 | United States | COM | 0 | 1,479 | +1,479 | $0 | $2,233 | +$2,233 | 2024-05-15 |
|---|